 | Monter d'un niveau |
Astolfi, M., Péant, B., Lateef, M. A., Rousset, N., Kendall-Dupont, J., Carmona, E., Monet, F., Saad, F., Provencher, D., Mes-Masson, A. M., & Gervais, T. (2016). Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy. Lab on a Chip, 16(2), 312-325. Lien externe
Astolfi, M., Lateef, A., Peant, B., Kendall-Dupont, J., Rousset, N., Saad, F., Provencher, D., Mes-Masson, A. M., & Gervais, T. (octobre 2015). Beyond spheroids: Human micro-dissected tumors as a patient-specific model to predict treatment response [Communication écrite]. 19th International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS 2015), Gyeongju, Korea, Republic of. Non disponible
Choi, B., Kollias, N., Zeng, H., Kang, H. W., Wong, B. J. F., Ilgner, J. F., Tearney, G. J., Gregory, K. W., Marcu, L., Skala, M. C., Campagnola, P. J., Mandelis, A., Morris, M. D., St-Georges-Robillard, A., Masse, M., Kendall-Dupont, J., Strupler, M., Patra, B., Jermyn, M., ... Gervais, T. (février 2016). Spectroscopic imaging system for high-throughput viability assessment of ovarian spheroids or microdissected tumor tissues (MDTs) in a microfluidic chip [Communication écrite]. Photonic Therapeutics and Diagnostics XII, San Francisco, California. Lien externe
Patra, B., Carmona, E., Lateef, M. A., Kendall-Dupont, J., Peant, B., Provencher, D., Mes-Masson, A. M., & Gervais, T. (octobre 2016). Are 3D spheroids always more resistant to chemotherapy than 2D cultures? A chip-based survey using ovarian cancer cell lines [Communication écrite]. 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS 2016), Dublin, Ireland. Non disponible
